Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts

被引:9
作者
Shah, Yajas [1 ,2 ]
Yang, Hua [3 ]
Mueller, Franco B. [3 ]
Li, Carol [3 ]
Rahim, Shab E. Gul [3 ]
Varma, Elly [3 ]
Salinas, Thalia [3 ,4 ]
Dadhania, Darshana M. [3 ,4 ]
Salvatore, Steven P. [5 ]
Seshan, Surya, V [5 ]
Sharma, Vijay K. [3 ]
Elemento, Olivier [1 ,2 ]
Suthanthiran, Manikkam [3 ,4 ]
Muthukumar, Thangamani [3 ,4 ,6 ]
机构
[1] Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY USA
[2] Weill Cornell Med Coll, Grad Program Physiol Biophys & Syst Biol, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, New York, NY USA
[4] NewYork Presbyterian Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA
[5] Weill Cornell Med Coll, Dept Pathol & Lab Med, Div Renal Pathol, New York, NY USA
[6] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, 525 East 68th St,Box 3, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
chronic active antibody-mediated rejection; kidney biopsy; kidney transplantation; natural killer cells; RNA sequencing; DONOR-SPECIFIC ANTIBODIES; NK CELLS; MOLECULAR DIAGNOSIS; INVOLVEMENT; MECHANISMS; RECIPIENTS; BIOPSIES; INJURY;
D O I
10.1016/j.kint.2023.11.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Natural killer (NK) cells mediate spontaneous cell -mediated cytotoxicity and antibody -dependent cell -mediated cytotoxicity. This dual functionality could enable their participation in chronic active antibody -mediated rejection (CA-ABMR). Earlier microarray profiling studies have not subcategorized antibody -mediated rejection into CA-ABMR and active-ABMR, and the gene expression pattern of CAABMR has not been compared with that of T cell -mediated rejection (TCMR). To fill these gaps, we RNA sequenced human kidney allograft biopsies categorized as CA-ABMR, active-ABMR, TCMR, or No Rejection (NR). Among the 15,910 genes identified in the biopsies, 60, 114, and 231 genes were uniquely overexpressed in CA-ABMR, TCMR, and active-ABMR, respectively; compared to NR, 50 genes were shared between CA-ABMR and active-ABMR, and 164 genes between CA-ABMR and TCMR. The overexpressed genes were annotated to NK cells and T cells in CA-ABMR and TCMR, and to neutrophils and monocytes in activeABMR. The NK cell cytotoxicity and allograft rejection pathways were enriched in CA-ABMR. Genes encoding perforin, granzymes, and death receptor were overexpressed in CA-ABMR versus active-ABMR but not compared to TCMR. NK cell cytotoxicity pathway gene set variation analysis score was higher in CA-ABMR compared to active-ABMR but not in TCMR. Principal component analysis of the deconvolved immune cellular transcriptomes separated CA-ABMR and TCMR from activeABMR and NR. Immunohistochemistry of kidney allograft biopsies validated a higher proportion of CD56D NK cells in CA-ABMR than in active-ABMR. Thus, CA-ABMR was exemplified by the overexpression of the NK cell cytotoxicity pathway gene set and, surprisingly, molecularly more like TCMR than active-ABMR.
引用
收藏
页码:347 / 363
页数:17
相关论文
共 50 条
  • [41] Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation
    Yazdani, Saleh
    Callemeyn, Jasper
    Gazut, Stephane
    Lerut, Evelyne
    de Loor, Henriette
    Wevers, Max
    Heylen, Line
    Saison, Carole
    Koenig, Alice
    Thaunat, Olivier
    Thorrez, Lieven
    Kuypers, Dirk
    Sprangers, Ben
    Noel, Laure-Helene
    Van Lommel, Leentje
    Schuit, Frans
    Essig, Marie
    Gwinner, Wilfried
    Anglicheau, Dany
    Marquet, Pierre
    Naesens, Maarten
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 188 - 198
  • [42] The Problem of Subclinical Antibody-mediated Rejection in Kidney Transplantation
    Filippone, Edward John
    Farber, John L.
    TRANSPLANTATION, 2021, 105 (06) : 1176 - 1187
  • [43] Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney
    Tiller, Gesa
    Lammerts, Rosa G. M.
    Karijosemito, Jessy J.
    Alkaff, Firas F.
    Diepstra, Arjan
    Pol, Robert A.
    Meter-Arkema, Anita H.
    Seelen, Marc. A.
    van den Heuvel, Marius C.
    Hepkema, Bouke G.
    Daha, Mohamed R.
    van den Born, Jacob
    Berger, Stefan P.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel
    Gambella, Alessandro
    Barreca, Antonella
    Osella-Abate, Simona
    Bottasso, Emanuel
    Giarin, Manuela Maria
    Papotti, Mauro
    Biancone, Luigi
    Metovic, Jasna
    Collemi, Giammarco
    Cassoni, Paola
    Bertero, Luca
    BIOMEDICINES, 2021, 9 (10)
  • [45] Early Ultrastructural Changes in Renal Allografts: Correlation With Antibody-Mediated Rejection and Transplant Glomerulopathy
    Haas, M.
    Mirocha, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (10) : 2123 - 2131
  • [46] Antibody-Mediated Rejection of Single Class I MHC-Disparate Cardiac Allografts
    Hattori, Y.
    Bucy, R. P.
    Kubota, Y.
    Baldwin, W. M., III
    Fairchild, R. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (08) : 2017 - 2028
  • [47] The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
    Delpire, Boris
    Van Loon, Elisabet
    Naesens, Maarten
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [48] Mechanism and treatment for chronic antibody-mediated rejection in kidney transplant recipients
    Sasaki, Hajime
    Tanabe, Tatsu
    Tsuji, Takahiro
    Hotta, Kiyohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (08) : 624 - 633
  • [49] Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
    Cernoch, Marek
    Hruba, Petra
    Kollar, Marek
    Mrazova, Petra
    Stranavova, Lucia
    Lodererova, Alena
    Honsova, Eva
    Viklicky, Ondrej
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [50] Chronic-active Antibody-mediated Rejection: To Belatacept or Not, That Is the HOT Question
    van der Zwan, Marieke
    Hesselink, Dennis A.
    Baan, Carla C.
    Clahsen-van Groningen, Marian C.
    TRANSPLANTATION, 2021, 105 (03) : 478 - 479